Abstract
Acute coronary syndromes (ACS) are responsible for the majority of deaths worldwide, and the acute myocardial infarction (AMI) highlights among them. In this subject, there are many treatments available to face this situation, for instance: angioplasty, coronary bypass and the usage of thrombolytics. However, all these options have risks and appear to be insufficient to diminish the threa…